XML 19 R46.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Mergers and Acquisitions - Additional Information (Details) (USD $) | 3 Months Ended | 1 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Mar. 31, 2015 | Mar. 31, 2014 | Feb. 28, 2015 | Aug. 08, 2014 | Dec. 31, 2014 | Mar. 06, 2014 | Sep. 30, 2012
Business Acquisition [Line Items] |  |  |  |  |  |  |
Revenues | $ 33,849,000 us-gaap_Revenues | $ 7,854,000 us-gaap_Revenues |  |  |  |  |
Net loss attributable to Intrexon | (27,097,000)us-gaap_NetIncomeLoss | (4,115,000)us-gaap_NetIncomeLoss |  |  |  |  |
ActoGeniX NV |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Percentage of outstanding common stock acquired |  |  | 100.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember |  |  |  |
Business acquisition, consideration paid, shares issued |  |  | 965,377 us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember |  |  |  |
Cash |  |  | 32,739,000 us-gaap_PaymentsToAcquireBusinessesGross / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember |  |  |  |
Fair value of total consideration transferred |  |  | 72,474,000 us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember |  |  |  |
Business combination, acquisition related cost | 446,000 us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember |  |  |  |  |  |
ActoGeniX NV | Selling, general and administrative |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Business combination, acquisition related cost | 409,000 us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_BusinessAcquisitionAxis = xon_ActoGeniXNVMember / us-gaap_IncomeStatementLocationAxis = us-gaap_SellingGeneralAndAdministrativeExpensesMember |  |  |  |  |  |
Trans Ova Genetics, LC |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Percentage of outstanding common stock acquired |  |  |  | 100.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Business acquisition, consideration paid, shares issued |  |  |  | 1,444,388 us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Cash |  |  |  | 63,625,000 us-gaap_PaymentsToAcquireBusinessesGross / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Fair value of total consideration transferred |  |  |  | 116,542,000 us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Business combination, acquisition related cost |  |  |  |  | 713,000 us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |
Deferred cash consideration |  |  |  | 20,115,000 us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Revenues | 18,926,000 us-gaap_Revenues / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |  |  |  |
Net loss attributable to Intrexon | 237,000 us-gaap_NetIncomeLoss / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |  |  |  |
Business combination, consideration transferred and noncontrolling interest |  |  |  | 127,875,000 xon_BusinessCombinationConsiderationTransferredandNoncontrollingInterest / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |
Possible future contingent payments to former equity holders |  |  |  |  |  |  | 6,000,000 xon_BusinessCombinationContingentConsiderationFuturePaymentsToEquityHoldersMaximum / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember
Possible future contingent payments to former equity holders, current valuation | 0 us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent / us-gaap_BusinessAcquisitionAxis = xon_TransOvaGeneticsLcMember |  |  |  |  |  |
Exemplar Genetics, LLC |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Cash paid to acquire noncontrolling interest |  |  | 1,566,000 xon_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseofInterestbyParentCashPortion / us-gaap_BusinessAcquisitionAxis = xon_ExemplarGeneticsLLCMember |  |  |  |
Shares issued to acquire noncontrolling interest |  |  | 307,074 xon_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseofInterestbyParentSharesIssuedbyParent / us-gaap_BusinessAcquisitionAxis = xon_ExemplarGeneticsLLCMember |  |  |  |
Medistem, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Percentage of outstanding common stock acquired |  |  |  |  |  | 100.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Business acquisition, consideration paid, shares issued |  |  |  |  |  | 714,144 us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Cash |  |  |  |  |  | 4,920,000 us-gaap_PaymentsToAcquireBusinessesGross / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Fair value of total consideration transferred |  |  |  |  |  | 24,995,000 us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Business combination, acquisition related cost |  |  |  |  | 680,000 us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |  |
Number of promissory notes settled upon the closing of the merger |  |  |  |  |  | 2 xon_NumberOfPromissoryNotesSettled / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Shares of merger consideration surrendered by acquiree management to reimburse for required payroll tax withholdings |  |  |  |  |  | 17,695 xon_SharesSurrenderedToPayWithholdingTaxesShares / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember |
Medistem, Inc. | Settlement of Promissory Notes |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Fair value of total consideration transferred |  |  |  |  |  | 707,000 us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember / us-gaap_NoncashOrPartNoncashAcquisitionsByUniqueDescriptionAxis = xon_PromissoryNotesMember |
Medistem, Inc. | Selling, general and administrative |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Business combination, acquisition related cost |  | $ 291,000 us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_BusinessAcquisitionAxis = xon_MedistemIncMember / us-gaap_IncomeStatementLocationAxis = us-gaap_SellingGeneralAndAdministrativeExpensesMember |  |  |  |  |
Minimum |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Weighted Average Useful Life (Years) | 2 years |  |  |  |  |  |
Minimum | Trans Ova Genetics, LC |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Weighted Average Useful Life (Years) |  |  |  | 3 years |  |  |
Maximum |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Weighted Average Useful Life (Years) | 14 years |  |  |  |  |  |
Maximum | Trans Ova Genetics, LC |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Weighted Average Useful Life (Years) |  |  |  | 9 years |  |  |

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer combined with noncontrolling interest. + References No definition available. + Details
Name: | xon_BusinessCombinationConsiderationTransferredandNoncontrollingInterest
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Contingent Consideration, Future Payments To Equity Holders, Maximum + References No definition available. + Details
Name: | xon_BusinessCombinationContingentConsiderationFuturePaymentsToEquityHoldersMaximum
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the cash portion of the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary. + References No definition available. + Details
Name: | xon_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseofInterestbyParentCashPortion
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the shares issued by the parent for purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary. + References No definition available. + Details
Name: | xon_ConsolidationLessthanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseofInterestbyParentSharesIssuedbyParent
Namespace Prefix: | xon_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of promissory notes settled upon the closing of the merger. + References No definition available. + Details
Name: | xon_NumberOfPromissoryNotesSettled
Namespace Prefix: | xon_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares surrendered by former management of acquiree to reimburse the entity for required payroll tax withholdings. + References No definition available. + Details
Name: | xon_SharesSurrenderedToPayWithholdingTaxesShares
Namespace Prefix: | xon_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_ActoGeniXNVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_ExemplarGeneticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_MedistemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_TransOvaGeneticsLcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |